Helliner Santulli

Helliner Santulli is a Senior Medical Director in Clinical Development with over twenty-five years of experience in the medical field. They hold a PhD and an MD from the University of Sao Paulo, as well as a Global Executive MBA from the University of Virginia Darden School of Business. Helliner has a strong background in endocrinology, particularly in energy metabolism, obesity, and diabetes, as well as liver diseases. Their recent roles include Senior Medical Director at Biogen/Reata Pharmaceuticals and at ACELYRIN, INC., with prior positions in notable companies such as Takeda and Novo Nordisk, focusing on Global Clinical Research & Development and Medical Regulatory Affairs.